These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 7295100

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. ["Middle molecules" as nonspecific regulators of phagocyte activity].
    Volchegorskiĭ IA, Vlasov AV, Livshits GE, Akhkiamov EM, Skobeleva NA, Lifshits RI, Ebert LIa.
    Biull Eksp Biol Med; 1995 Feb; 119(2):159-62. PubMed ID: 7670039
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A compound from uremic plasma and from normal urine isolated by liquid chromatography and identified by nuclear magnetic resonance.
    Gallice P, Monti JP, Crevat A, Durand C, Murisasco A.
    Clin Chem; 1985 Jan; 31(1):30-4. PubMed ID: 3965216
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Uremic toxins and the elusive middle molecules.
    Schoots A, Mikkers F, Cramers C, de Smet R, Ringoir S.
    Nephron; 1984 Jan; 38(1):1-8. PubMed ID: 6472528
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A, Myśliwiec M, Soszka J.
    Pol Tyg Lek; 1984 Jan; 45(40-41):810-3. PubMed ID: 2096374
    [Abstract] [Full Text] [Related]

  • 35. Analysis of plasma middle molecular fraction in uremic patients.
    Kovalishin YaF.
    Biomater Artif Cells Artif Organs; 1987 Jan; 15(3):605-10. PubMed ID: 3440134
    [Abstract] [Full Text] [Related]

  • 36. Isotachophoretic separation of middle molecule peptides in uremic body fluids.
    Zimmerman L, Baldesten A, Bergström J, Fürst P.
    Clin Nephrol; 1980 Apr; 13(4):183-8. PubMed ID: 7379369
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Uremic middle molecules in non-dialyzed azotemic patients: relation to symptoms and clinical biochemistries.
    Asaba H, Alvestrand A, Bergström J, Fürst P, Yahiel V.
    Clin Nephrol; 1982 Feb; 17(2):90-5. PubMed ID: 7067171
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Scaling up in isolation of medium-size uraemic toxins.
    Gallice PM, Crevat AD, Berland YF.
    J Chromatogr; 1991 Feb 22; 539(2):449-53. PubMed ID: 2045455
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.